The SUCCEED Trial

Condition

  • Stroke


Study Name

Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: The SUCCEED Trial (IRB no. 40111)


Summary

This study focuses on patients who have had a recent transient ischemic attack (TIA), ischemic stroke or hemorrhagic stroke, and who have received care at Cedars-Sinai. The purpose of the study is to evaluate whether an outpatient care program called SUCCEED reduces the risk of a future stroke among individuals with a recent stroke. Researchers will also measure the cost of conducting such a program.

Patients will be randomly assigned to either a care management and community health worker-led intervention group or a “usual care” group to improve management of stroke risk factors.


Eligibility

Key Inclusion Criteria:

  • Patients with onset of ischemic stroke, hemorrhagic stroke or TIA within the past three months
  • At least 40 years old
  • Systolic blood pressure greater than 120 mm Hg

Key Exclusion Criteria:

  • Speaks language other than English, Spanish, Korean, Mandarin, and Cantonese
  • Active drug or alcohol use or dependence that would interfere with study requirements
  • Serious illness (requiring systemic treatment and/or hospitalization)

Please see additional list of inclusion and exclusion criteria.


Principal Investigator

Shlee Song, MD


Contact

Felice Lin
Phone: 310-248-7645
Email: felice.lin@cshs.org